Target intelligence / Profile preview

Human Papillomavirus (HPV) Neutralizing Antibodies (HPV Neutralizing Antibodies)

Target
HPV Neutralizing Antibodies
Molecular classification
Immunoglobulin, Antibody
01

Overview

HPV neutralizing antibodies are antibodies produced by the human immune system in response to HPV antigens, either through natural infection or vaccination. These antibodies target the viral capsid proteins, particularly L1, and prevent HPV infection by blocking viral entry into host cells. The primary mechanism of action of HPV vaccines is the elicitation of these neutralizing antibodies. They are mostly type-specific but sometimes display cross-reactivity.

Other names
Anti-HPV AntibodiesHPV-specific ImmunoglobulinsHPV Neutralizing Abs
02

Mechanism of action

Binding to HPV virions, blocking attachment and entry into host cells, promoting viral clearance via Fc-mediated effector functions.

03

Biological functions

Neutralization of viral infectivityPrevention of HPV infectionAdaptive immune responseViral clearanceOpsonization
04

Disease associations

Prevention of HPV infectionPrevention of cervical cancerPrevention of anogenital wartsPrevention of oropharyngeal cancerProtection against HPV-related diseases
05

Safety considerations

Potential for waning antibody titers over timeType-specificity limits broad protection against all HPV typesRequirement for booster doses to maintain long-term immunity
06

Interacting drugs

HPV vaccines (e.g., Gardasil, Cervarix, Gardasil 9)
07

Biomarkers

Anti-HPV antibody titers (IgG)Neutralizing antibody titersMemory B cell response to HPV antigens

Beyond the preview

Go deeper on Human Papillomavirus (HPV) Neutralizing Antibodies (HPV Neutralizing Antibodies).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Papillomavirus (HPV) Neutralizing Antibodies (HPV Neutralizing Antibodies).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call